Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: December 2011

Chapter 3 - Hemodynamic management of pre-eclampsia and eclampsia

References

1. SibaiB, DekkerG & KupfermincM. Pre-eclampsia. Lancet 2005; 365: 785–99.
2. World Health Organization. The World Health Report. Chapter 4: Risking death to give life. www.who.int/whr/2005/chapter4/en/index1.html [Accessed July 2011]
3. CartyD M, DellesC & DominiczakA F. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 2008; 18: 186–94.
4. MageeL A, HelewaM, MoutquinJ Met al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynecol Can 2008; 30: S1–S48.
5. RedmanC W & SargentI L. Latest advances in understanding preeclampsia. Science 2005; 308: 1592–4.
6. MurphyD J & StriateG M. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000; 19: 221–31.
7. NessR B & SibaiB M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40–9.
8. RobertsJ M & GammillH S. Preeclampsia: recent insights. Hypertension 2005; 46: 1243–9.
9. RobertsJ M & HubelC A. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30: S32–7.
10. CudihyD & LeeR V. The pathophysiology of pre-eclampsia: current clinical concepts. J Obstetrics Gynaecol 2009; 29: 576–82.
11. RobertsJ M & LainK Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002; 23: 359–72.
12. ValensiseH, VasapolloB, GagliardiGet al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52: 873–80.
13. BolteA C, DekkerG A, van EyckJet al. Lack of agreement between central venous pressure and pulmonary capillary wedge pressure in preeclampsia. Hypertens Pregnancy 2000; 19: 261–71.
14. OhashiY, IbrahimH, FurtadoLet al. Non-invasive hemodynamic assessment of non-pregnant, healthy pregnant and preeclamptic women using bio-reactance. Brazil J Anesth 2010; 60: 603–13.
15. San-FrutosL M, FernandezR, AlmagroJet al. Measure of hemodynamic patterns by thoracic electrical bioimpedance in normal pregnancy and in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 121: 149–53.
16. DyerR A, Piercy, J L, ReedA Ret al. Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia. Anesthesiology 2008; 108: 802–11.
17. Conde-AgudeloA, VillarJ & LindheimerM. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104: 1367–91.
18. GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77: 127–31.
19. DuleyL, Henderson-SmartD J, MeherSet al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; 2: CD004659.
20. BujoldE, RobergeS, LacasseYet al. Prevention of pre-eclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402–14.
21. LewisG & DrifeJ. Why Mothers Die 1997–1999: The Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2001.
22. MageeL A, ChamC, WatermanE Jet al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327: 955–60.
23. MageeL A, MiremadiS, LiJet al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005; 193: 153–63.
24. AbalosE, DuleyL, SteynD Wet al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001; 2: CD002252.
25. AbalosE, DuleyL, SteynD & Henderson-SmartD. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007; 1: CD002252.
26. MageeL A & DuleyL. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2000; 4: CD002863.
27. DuleyL, Henderson-SmartD J & MeherS. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006; 3: CD001449.
28. SibaiB M. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105: 402–10.
29. DuleyL, GülmezogluA M, Henderson-SmartD J & ChouD. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010; 11: CD000025.
30. DuleyL, Henderson-SmartD J, WalkerG J & ChouD. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2010; 12: CD000127.
31. DuleyL, Henderson-SmartD J & ChouD. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2010; 10: CD000128.
32. EuserA G & CipollaM J. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009; 40: 1169–75.
33. HaramK, SvendsenE & AbildgaardU. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 2009; 9: 8.
34. O’BrienJ M, ShumateS A, SatchwellS L, MilliganD A & BartonJ R. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002; 186: 475–9.
35. WoudstraD M, ChandraS, HofmeyrG J, DowswellT. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2010; 9: CD008148.
36. TihtonenK, KoobiT, Yli-HankalaA, et al. Maternal haemodynamics in preeclampsia compared with normal pregnancy during caesarean delivery. BJOG 2006; 113: 657–63.
37. RamanathanJ, ColemanP & SibaiB. Anesthetic modification of hemodynamic and neuroendocrine stress responses to cesarean delivery in women with severe preeclampsia. Anesth Analg 1991; 73: 772–9.
38. American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Amended October 18, 2006. http://www.asahq.org/publicationsAndServices/OBguide.pdf.
39. LeducL, WheelerJ M, KirshonBet al. Coagulation profile in severe preeclampsia. Obstet Gynecol 1992; 79: 14–18.
40. MartinJ N Jr , BlakeP G, PerryK G Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500–9.
41. VisalyaputraS, RodanantO, SomboonviboonWet al. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study. Anesth Analg 2005; 101: 862–8.
42. HoodD D & CurryR. Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey. Anesthesiology 1999; 90: 1276–82.
43. WallaceD H, LevenoK J, CunninghamF Get al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol 1995; 86: 193–9.
44. AyaA G, ManginR, ViallesNet al. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison. Anesth Analg 2003; 97: 867–72.
45. NisellH, HjemdahlP & LindeB. Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clin Physiol 1985; 5: 479–93.
46. RobinsonD A. Epinephrine should not be used with local anesthetics for epidural anesthesia in pre-eclampsia. Anesthesiology 1987; 66: 577–8.
47. VanWijkM J, BoerK, van der MeulenE Tet al. Resistance artery smooth muscle function in pregnancy and preeclampsia. Am J Obstet Gynecol 2002; 186: 148–54.
48. LewisG (ed). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 2003–2005. 2007; www.cemach.org.uk.
49. HuangC J, FanY C & TsaiP S. Differential impacts of modes of anaesthesia on the risk of stroke among preeclamptic women who undergo Caesarean delivery: a population-based study. Br J Anaesth 2010; 105: 818–26.
50. LangesæterE, RosselandL A & StubhaugA. Haemodynamic effects of oxytocin in women with severe preeclampsia. Int J Obstet Anesth 2011; 20: 26–9.
51. MartinJ N, ThigpenB D, MooreR Cet al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246–54.
52. SibaiM B, MabieB C, HarveyC J & GonzalezA R. Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol 1987: 156; 1174–9.
53. BauerS T & ClearyK L. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol 2009; 33: 158–65.
54. BenedettiT J, KatesR & WilliamsV. Hemodynamic observations in severe pre-clampsia complicated by pulmonary edema. Am J Obstet Gynecol 1985; 152: 330–4.